BioMarin to Participate in Three Investor Conferences in March

Rhea-AI Summary

BioMarin Pharmaceutical (NASDAQ: BMRN) announced participation in three investor conferences in March 2023. Management will be presenting at the Cowen Healthcare Conference on March 8 at 10:30 am ET, followed by the Barclays Global Healthcare Conference on March 15 at 9:30 am ET. Additionally, they will speak at the Jefferies Biotech on the Bay Summit on March 16 in Miami. The events will be webcast live, and replays will be available for a limited time on BioMarin's website.

BioMarin, founded in 1997, focuses on developing therapies for rare genetic disorders, with a strong pipeline of treatments.

Cowen Healthcare Conference on March 8 in Boston

Barclays Global Healthcare Conference on March 15 in Miami

Jefferies Biotech on the Bay Summit on March 16 in Miami

SAN RAFAEL, Calif., March 2, 2023 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that management will participate in three upcoming investor conferences in March. Management will present at the Cowen Healthcare Conference on Wednesday, March 8^th at 10:30am ET and at the Barclays Global Healthcare Conference on Wednesday, March 15^th at 9:30am ET. 

For these conferences, that will be webcast live, please access by visiting BioMarin's website at https://investors.biomarin.com/. A replay of the webcasts will be available for the events with presentations through the Company's website for a limited time following the conferences.

About BioMarin
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery. The company develops and commercializes targeted therapies that address the root cause of the genetic conditions. BioMarin's unparalleled research and development capabilities have resulted in eight transformational commercial therapies for patients with rare genetic disorders. The company's distinctive approach to drug discovery has produced a diverse pipeline of commercial, clinical, and pre-clinical candidates that address a significant unmet medical need, have well-understood biology, and provide an opportunity to be first-to-market or offer a substantial benefit over existing treatment options. For additional information, please visit www.biomarin.com.

Contacts:
Investors	Media
Traci McCarty	Marni Kottle
BioMarin Pharmaceutical Inc.	BioMarin Pharmaceutical Inc.
(415) 455-7558	(650) 374-2803

View original content to download multimedia:https://www.prnewswire.com/news-releases/biomarin-to-participate-in-three-investor-conferences-in-march-301760655.html

SOURCE BioMarin Pharmaceutical Inc.

FAQ

When will BioMarin be presenting at the Cowen Healthcare Conference?

BioMarin will present at the Cowen Healthcare Conference on March 8, 2023, at 10:30 am ET.

What dates will BioMarin participate in investor conferences in March 2023?

BioMarin will participate in three investor conferences: March 8, March 15, and March 16, 2023.

Where will the Barclays Global Healthcare Conference take place?

The Barclays Global Healthcare Conference will take place in Miami on March 15, 2023.

Will the BioMarin conference presentations be available for later viewing?

Yes, the presentations will be webcast live and available for replay on BioMarin's website for a limited time.

What is the focus of BioMarin's drug development?

BioMarin focuses on developing targeted therapies for rare genetic disorders.